Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 143,630 ordinary shares between August 17th and August 21st, 2026, as part of its share buyback program. The weighted average purchase price across these transactions was approximately 845.6 pence per share, with individual share prices ranging from 832.50 pence to 866.50 pence. The company intends to cancel these repurchased shares.

Disclaimer*

Fevertree Drinks PLC
25 August 2026
 

25th August 2026                   

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 17th August to 21st August 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

17 August 2026

XLON

853.5254

28,423

839.5000

866.5000

17 August 2026

AIMX

845.2000

20,000

845.2000

845.2000

18 August 2026

XLON

846.0929

16,353

838.0000

852.5000

19 August 2026

XLON

839.4961

37,444

832.5000

842.0000

19 August 2026

AIMX

835.5000

15,936

835.5000

835.5000

20 August 2026

XLON

842.6699

27,112

832.5000

849.5000

21 August 2026

XLON

849.8050

8,366

845.5000

854.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/8575R_1-2026-8-24.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings